Bausch Health Leads HY Trading on $600M KKR Financing Facility

A 2026 bond of Bausch Health rises in high yield secondary trading Friday, after the pharmaceutical company entered into $600 million non-recourse financing facility with KKR.

• Bausch’s 9.250% bond due April 2026 rose 2.943 cents on the dollar to 86.563 cents as of 11:38am in New York, according to Trace
• The proceeds from the facility are to be used for general corporate purposes, and it provides access to additional liquidity for approximately five years, Bausch said in a statement

To contact the reporter on this story:
Richard Annerquaye Abbey in New York at rabbey5@bloomberg.net

To contact the editors ...